Recent smell loss is the best predictor of COVID-19: a preregistered, cross-sectional study [PrePrint]
Gerkin, Richard C; Ohla, Kathrin; Veldhuizen, Maria Geraldine; Joseph, Paule V; Kelly, Christine E; Bakke, Alyssa J; Steele, Kimberley E; Farruggia, Michael C; Pellegrino, Robert; Pepino, Marta Y; Bouysset, Cédric; Soler, Graciela M; Pereda-Loth, Veronica; Dibattista, Michele; Cooper, Keiland W; Croijmans, Ilja; Di Pizio, Antonella; Ozdener, M Hakan; Fjaeldstad, Alexander W; Lin, Cailu; Sandell, Mari A; Singh, Preet B; Brindha, V Evelyn; Olsson, Shannon B; Saraiva, Luis R; Ahuja, Gaurav; Alwashahi, Mohammed K; Bhutani, Surabhi; D'Errico, Anna; Fornazieri, Marco A; Golebiowski, Jérôme; Hwang, Liang-Dar; Öztürk, Lina; Roura, Eugeni; Spinelli, Sara; Whitcroft, Katherine L; Faraji, Farhoud; Fischmeister, Florian Ph S; Heinbockel, Thomas; Hsieh, Julien W; Huart, Caroline; Konstantinidis, Iordanis; Menini, Anna; Morini, Gabriella; Olofsson, Jonas K; Philpott, Carl M; Pierron, Denis; Shields, Vonnie D C; Voznessenskaya, Vera V; Albayay, Javier; Altundag, Aytug; Bensafi, Moustafa; Bock, María Adelaida; Calcinoni, Orietta; Fredborg, William; Laudamiel, Christophe; Lim, Juyun; Lundström, Johan N; Macchi, Alberto; Meyer, Pablo; Moein, Shima T; SantamarÃa, Enrique; Sengupta, Debarka; DomÃnguez, Paloma Paloma; Yanık, Hüseyin; Boesveldt, Sanne; de Groot, Jasper H B; Dinnella, Caterina; Freiherr, Jessica; Laktionova, Tatiana; Mariño, Sajidxa; Monteleone, Erminio; Nunez-Parra, Alexia; Abdulrahman, Olagunju; Ritchie, Marina; Thomas-Danguin, Thierry; Walsh-Messinger, Julie; Al Abri, Rashid; Alizadeh, Rafieh; Bignon, Emmanuelle; Cantone, Elena; Cecchini, Maria Paola; Chen, Jingguo; Guà rdia, Maria Dolors; Hoover, Kara C; Karni, Noam; Navarro, Marta; Nolden, Alissa A; Mazal, Patricia Portillo; Rowan, Nicholas R; Sarabi-Jamab, Atiye; Archer, Nicholas S; Chen, Ben; Di Valerio, Elizabeth A; Feeney, Emma L; Frasnelli, Johannes; Hannum, Mackenzie; Hopkins, Claire; Klein, Hadar; Mignot, Coralie; Mucignat, Carla; Ning, Yuping; Ozturk, Elif E; Peng, Mei; Saatci, Ozlem; Sell, Elizabeth A; Yan, Carol H; Alfaro, Raul; Cecchetto, Cinzia; Coureaud, Gérard; Herriman, Riley D; Justice, Jeb M; Kaushik, Pavan Kumar; Koyama, Sachiko; Overdevest, Jonathan B; Pirastu, Nicola; Ramirez, Vicente A; Roberts, S Craig; Smith, Barry C; Cao, Hongyuan; Wang, Hong; Balungwe, Patrick; Baguma, Marius; Hummel, Thomas; Hayes, John E; Reed, Danielle R; Niv, Masha Y; Munger, Steven D; Parma, Valentina
BACKGROUND:COVID-19 has heterogeneous manifestations, though one of the most common symptoms is a sudden loss of smell (anosmia or hyposmia). We investigated whether olfactory loss is a reliable predictor of COVID-19. METHODS:This preregistered, cross-sectional study used a crowdsourced questionnaire in 23 languages to assess symptoms in individuals self-reporting recent respiratory illness. We quantified changes in chemosensory abilities during the course of the respiratory illness using 0-100 visual analog scales (VAS) for participants reporting a positive (C19+; n=4148) or negative (C19-; n=546) COVID-19 laboratory test outcome. Logistic regression models identified singular and cumulative predictors of COVID-19 status and post-COVID-19 olfactory recovery. RESULTS:Both C19+ and C19- groups exhibited smell loss, but it was significantly larger in C19+ participants (mean±SD, C19+: -82.5±27.2 points; C19-: -59.8±37.7). Smell loss during illness was the best predictor of COVID-19 in both single and cumulative feature models (ROC AUC=0.72), with additional features providing no significant model improvement. VAS ratings of smell loss were more predictive than binary chemosensory yes/no-questions or other cardinal symptoms, such as fever or cough. Olfactory recovery within 40 days was reported for ~50% of participants and was best predicted by time since illness onset. CONCLUSIONS:As smell loss is the best predictor of COVID-19, we developed the ODoR-19 tool, a 0-10 scale to screen for recent olfactory loss. Numeric ratings ≤2 indicate high odds of symptomatic COVID-19 (10
PMCID:7386529
PMID: 32743605
ISSN: n/a
CID: 4553642
Improving Communication with LGBTQ Patients: A Pilot Curriculum During the Psychiatry Clerkship
Fadus, Matthew C; Peterson, Neal K; Jilich, Celeste L; Kantor, Edward M; Beckert, David R; Reed, Jace M; Valadez, Emilio A; Brendle, Timothy A
PMID: 31820369
ISSN: 1545-7230
CID: 4552792
A Case of Kratom-induced Seizures [Case Report]
Afzal, Hasnain; Esang, Michael; Rahman, Sabreen
Kratom or Mitragna speciosa is a tropical tree that is indigenous to Southeast Asia, where it has been used for various medicinal reasons. In the West, it is used in the self-treatment of opioid withdrawal, pain, and a variety of mood and anxiety states. Two active ingredients in kratom are mitragynine and 7-hydroxymitragynine, which have affinity at the mu-opioid receptor among others. Kratom is easily available over the Internet and its use is increasing in the United States. It is currently listed by the Drug Enforcement Administration as a drug of concern. In 2017, the U.S. Food and Drug Administration started issuing a series of warnings about kratom, and by early 2018, it released a statement identifying 44 deaths related to kratom use. The Centers for Disease Control and Prevention has also reported 91 deaths directly linked to kratom use in 2019. Although its safety profile needs additional research for clarification, there have been reports of kratom-induced or kratom-related respiratory depression, hypothyroidism, secondary hypogonadism, hyperprolactinemia, psychosis, and seizures. We report a case of kratom-induced tonic-clonic seizures in a 27-year-old Caucasian male with a psychiatric history of anxiety, attention-deficit/hyperactivity disorder, benzodiazepine use disorder, and opioid use disorder. He was hospitalized after a witnessed tonic-clonic seizure. There was no significant metabolic abnormality on laboratory testing. Spinal cord and brain imaging were unremarkable, whereas his urine toxicology was positive for opioids only, which was likely a false-positive result due to cross-reactivity with his sleeping aids. He was evaluated by the Consultation-Liaison Psychiatry team for psychotic symptoms. On evaluation, the patient's psychosis had resolved, but he endorsed racing thoughts, significant anxiety, and insomnia. He admitted to drinking three to four 8-mL bottles of Kratom daily for one-and-a-half years to self-medicate his anxiety after losing his health insurance. In the hospital, he was treated with anxiolytics, counseled to abstain from Kratom use, and was referred for substance use disorder treatment. This case highlights the life-threatening complications of Kratom that is easily available online.
PMCID:7001130
PMID: 32051800
ISSN: 2168-8184
CID: 4552872
Development of wellness programs during the COVID-19 pandemic response
Spray, Amanda M.; Patel, Nikhil A.; Sood, Ashvin; Wu, Stephanie X.; Simon, Naomi M.; Podbury, Rachel; Vasserman, Ariela; Caravella, Rachel A.; Silverman, Yona; Pochtar, Randi; Liaw, K. Ron Li; Ackerman, Marra G.
Health care workers are on the front lines of the recent pandemic, facing significant challenges to their physical and mental health. This article details the efforts undertaken by a health care system and two academically affiliated hospital systems to provide emotional support to their frontline staff. The multipronged approach describes coordinating efforts to decrease duplication of services and to increase centralization of information. This included enhancing pathways for faculty, staff, and trainees to obtain individual and group treatment and to have access to highquality self-help resources. Continuous feedback has been elicited to ensure that efforts are consistent with expressed needs and in turn services undergo modifications as needed. This article seeks to provide an overview of how one health system has thus far approached the important issue of staff support as well as the challenges experienced and lessons learned along the way.
SCOPUS:85087423070
ISSN: 0048-5713
CID: 4543512
Parent Management Training Oregon Model and Family-Based Services as Usual for Behavioral Problems in Youth: A National Randomized Controlled Trial in Denmark
Scavenius, Christoffer; Chacko, Anil; Lindberg, M R; Granski, Megan; Vardanian, M M; Pontoppidan, Maiken; Hansen, Helle; Eiberg, Misja
This randomized control trial used intent-to-treat analyses to compare parent management training-Oregon model (PMTO) (N = 64) to family-based services as usual (SAU) (N = 62) in 3.5-13-year-old children and their families in Denmark. Outcomes were parent report of child internalizing and externalizing problems, parenting efficacy, parenting stress, parent sense of coherence, parent-report of life satisfaction, and parental depressive symptoms. Outcomes were measured at pretreatment, post-treatment, and 18-20 months post-treatment. Results demonstrated that both PMTO and family-based SAU resulted in significant improvements in child externalizing and internalizing problems, parenting efficacy, as well as parent-reported stress and depressive symptoms, life satisfaction, and aspects of sense of cohesion. Effect sizes at post-treatment and follow-up were in the small to moderate range, consistent with prior PMTO evaluations. However, there were no significant differences between PMTO and family-based SAU. Further research on the process and content of family-based SAU is needed to determine how this approach overlaps with and is distinct from PMTO.
PMID: 32705460
ISSN: 1573-3327
CID: 4542822